Abeona Therapeutics (ABEO) Enterprise Value (2011 - 2026)

Abeona Therapeutics' Enterprise Value history runs 17 years deep, the most recent figure standing at -$168.3 million for Q1 2026.

• In Q1 2026, Enterprise Value fell 99.95% year-over-year to -$168.3 million; the TTM figure through Mar 2026 stood at -$168.3 million (down 99.95% YoY), while the FY2025 annual figure was -$191.4 million, down 95.19% from the prior year.
• Enterprise Value for Q1 2026 stood at -$168.3 million, up from -$191.4 million in the prior quarter.
• The five-year high for Enterprise Value was -$16.9 million in Q1 2022, with the low at -$225.5 million in Q2 2025.
• The 5-year median for Enterprise Value is -$54.1 million (2023), against an average of -$88.6 million.
• The sharpest annual moves came in 2022 and 2023: Enterprise Value jumped 80.76% in 2022, then tumbled 197.75% in 2023.
• Abeona Therapeutics' Enterprise Value stood at -$52.5 million in 2022, then declined by 0.15% to -$52.6 million in 2023, then plunged by 86.55% to -$98.1 million in 2024, then slumped by 95.19% to -$191.4 million in 2025, then gained by 12.09% to -$168.3 million in 2026.
• Business Quant data shows ABEO's Enterprise Value at -$168.3 million in Q1 2026, -$191.4 million in Q4 2025, and -$207.5 million in Q3 2025.